Efg Asset Management (Americas) Corp. Abb Vie Inc. Transaction History
Efg Asset Management (Americas) Corp.
- $508 Million
- Q4 2024
A detailed history of Efg Asset Management (Americas) Corp. transactions in Abb Vie Inc. stock. As of the latest transaction made, Efg Asset Management (Americas) Corp. holds 11,835 shares of ABBV stock, worth $2.54 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
11,835
Previous 10,195
16.09%
Holding current value
$2.54 Million
Previous $2.01 Million
4.47%
% of portfolio
0.41%
Previous 0.4%
Shares
16 transactions
Others Institutions Holding ABBV
# of Institutions
4,105Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$37.1 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$29.2 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$17.1 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$11.1 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.5 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $379B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...